MedPath

Yabao Pharmaceutical Group Co. Ltd.

Ownership
-
Established
1999-01-26
Employees
2.2K
Market Cap
-
Website
www.yabao.com.cn
Introduction

The company takes “join hands with health to create an oasis of life” as its corporate mission, integrating R&D, production, sales, logistics, and cultivation of Chinese herbal medicines and medicinal products. Mainly engaged in R&D, production and sales of pharmaceutical products. The company's main products include Chinese and Western medicine preparations, adhesives, APIs and pharmaceutical packaging materials. Corporate honors: National Certified Enterprise Technology Center; Advanced Collective; China's Outstanding Quality and Credit Construction Enterprise; “2022 China Innovative Pharmaceutical Enterprise”; “2022 Top 100 Chinese Medicine Enterprises”, 39th place. It received honors such as “China's Top 100 Pharmaceutical Industry Enterprises of the Year” and “2022 Best Industrial Enterprise in China Pharmaceutical R&D Product Line” from the China Pharmaceutical Industry Information Center, and won honors such as the “Shipkin Award”, the highest honor in the industry.

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

251

NMPA:251

Drug Approvals

Phloroglucinol Injection

Product Name
间苯三酚注射液
Approval Number
国药准字H20253636
Approval Date
Mar 18, 2025
NMPA

Nifedipine Controlled-release Tablets

Product Name
硝苯地平控释片
Approval Number
国药准字H20244594
Approval Date
Jul 30, 2024
NMPA

肤痒胶囊

Approval Number
国药准字Z20090734
Approval Date
Feb 29, 2024
NMPA

安神补脑胶囊

Approval Number
国药准字Z20090131
Approval Date
Feb 29, 2024
NMPA

葫芦素片

Approval Number
国药准字Z20093150
Approval Date
Feb 29, 2024
NMPA

Mosapride Citrate Tablets

Product Name
枸橼酸莫沙必利片
Approval Number
国药准字H20090158
Approval Date
Feb 29, 2024
NMPA

Thioctic Acid Tablets

Product Name
硫辛酸片
Approval Number
国药准字H20234571
Approval Date
Nov 28, 2023
NMPA

Thioctic Acid Tablets

Product Name
硫辛酸片
Approval Number
国药准字H20234570
Approval Date
Nov 28, 2023
NMPA

消栓通络片

Approval Number
国药准字Z20184085
Approval Date
Nov 24, 2023
NMPA

脑络通胶囊

Approval Number
国药准字Z20184082
Approval Date
Nov 24, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 26
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.